INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 146 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q4 2022. The put-call ratio across all filers is 0.96 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $870,954 | +71.3% | 46,977 | +2.2% | 0.21% | +92.8% |
Q2 2023 | $508,506 | -24.2% | 45,977 | -8.0% | 0.11% | -45.9% |
Q1 2023 | $671,191 | -14.9% | 49,977 | -21.6% | 0.20% | +19.2% |
Q4 2022 | $788,921 | +335.9% | 63,777 | +392.3% | 0.17% | +177.4% |
Q3 2022 | $181,000 | – | 12,954 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Samsara BioCapital, LLC | 640,688 | $9,514,000 | 1.49% |
CM Management, LLC | 45,000 | $668,000 | 0.50% |
EULAV Asset Management | 660,000 | $9,801,000 | 0.26% |
DLD Asset Management, LP | 225,200 | $3,346,000 | 0.24% |
Virtus ETF Advisers LLC | 21,387 | $318,000 | 0.14% |
GSA CAPITAL PARTNERS LLP | 79,145 | $1,175,000 | 0.12% |
Hennion & Walsh Asset Management, Inc. | 136,720 | $2,030,000 | 0.11% |
ALTRINSIC GLOBAL ADVISORS LLC | 168,800 | $2,507,000 | 0.08% |
Inspire Investing, LLC | 31,868 | $473,000 | 0.06% |
DUALITY ADVISERS, LP | 51,196 | $760,000 | 0.06% |